HIF-2Α MUTATED CANCERS

Clinical trials for HIF-2Α MUTATED CANCERS explained in plain language.

Never miss a new study

Get alerted when new HIF-2Α MUTATED CANCERS trials appear

Sign up with your email to follow new studies for HIF-2Α MUTATED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets multiple rare cancers in major trial

Disease control Recruiting now

This study is testing an oral medication called belzutifan for people with advanced rare tumors, including pheochromocytoma, pancreatic neuroendocrine tumors, VHL disease-associated tumors, and certain gastrointestinal cancers. The main goal is to see how well the drug shrinks tu…

Matched conditions: HIF-2Α MUTATED CANCERS

Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

HIF-2Α MUTATED CANCERS

Get alerted when new HIF-2Α MUTATED CANCERS trials appear

New pill targets multiple rare cancers in major trial